よりよい白血病治療のために
HOME >> JALSG-KSH(Korean society of Hematology) AML/MDS WP joint symposium

JALSG-KSH(Korean society of Hematology) AML/MDS WP joint symposium

Date: Dec 19 (Sun) 9:00-12:00
Venue: Nagoya University Hospital (鶴友会館、名大医学部、鶴舞)
Subtitle: Toward cooperative study between Japan and Korea


Opening remarks (9:00-9:05)
Tomoki Naoe (Nagoya University)

Session 1: Chromosomal abnormalities in AML (9:05-9:45)
Chairman: Kazunori Ohnishi (Hamamatsu University)
Chairman: Chul Soo Kim (Inha University)


Tomohiko Taki (Kyoto Prefectural Medical University)
     Karyotype analyses in AML97 and AML201 (Tentative)

Hyeoung-Joon Kim (Chonnam National University)
Chromosomal abnormalities in Korean AML patients


Session 2: AML genome (9:45-10:25)
Chairman: Yasushi Miyazaki (Nagasaki University)
Chairman:TBD (KSH)


Dong Soon Lee (Seoul National University)
Application of bio-cell chip technology on investigation of the genomic changes in AML

Seishi Ogawa(University of Tokyo)
     Search for genetics base of AML using high-speed resequence technology


Coffee break (10:25-10:45)


Session 3:Prognostic stratification of CBF-AML (tentative) (10:45-11:45)
Chairman: Yoo Hong Min (Yonsei University)
Chairman: Shuichi Miyawaki (Tokyo Metropolitan Ohtsuka Hospital)

Ho-Jin Shin (Pusan National University)
Prognostic model in t(8;21) AML in Korea

Norio Asou (Kumamoto University)
KIT mutations in CBF-AML (tentative)

Dong Hwan Kim (Sungkyunkwan University)
Genome-wide SNP array-based approach to detect micro-cytogenetic lesions and KIT mutation to improve treatment outcomes in patients with core-binding factor-positive AML


Closing remarks
Yoo-Hong Min (Yonsei University)